CD8A and cancer: Secondary outcomes included immune function (CD4+, CD8 + counts, CD4+/CD8 + ratio), hematological parameters, cancer-related fatigue (PFS), self-care ability (ESCA), quality of life (GQOLI-74), adverse reactions (CTCAE 5.0), and nursing satisfaction.